Get started
Author

Ronwyn I Van Eeden

Observed names: Dr Ronwyn Van Eeden, R Van Eeden, R. Van Eeden, R.I. Van Eeden, Ronwyn van Eeden
ORCID: 0000-0003-4600-0308
Observed ORCID: 0000-0003-4600-0308
OpenAlex ID: A5038859207
Supportive care for patients undergoing immunotherapy
2017 · Bernardo Leon Rapoport, Ronwyn van Eeden, et al. · Supportive Care in Cancer · 75
Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
2019 · Ronwyn van Eeden, Bernardo L. Rapoport, et al. · Frontiers in Oncology · 47
PDF
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers
2023 · Evelyn Jiagge, Dexter X. Jin, et al. · Cancer Cell · 37
Lung Cancer in South Africa
2019 · Ronwyn van Eeden, Mariza Tunmer, et al. · Journal of Thoracic Oncology · 28
PDF
Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
2018 · Bernardo Leon Rapoport, Matti Aapro, et al. · BMC Cancer · 19
PDF
Current trends in the management of anaemia in solid tumours and haematological malignancies
2016 · Ronwyn van Eeden, Bernardo L. Rapoport · Current Opinion in Supportive and Palliative Care · 18
Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Patients undergoing Treatment with Nivolumab for Recurrent Non-Small-Cell Lung Cancer
2020 · Bernardo L Rapoport, Annette J Theron, et al. · Lung Cancer Management · 15
PDF
Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
2019 · B.L. Rapoport, J. Barnard-Tidy, et al. · Annals of Oncology · 11
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials
2022 · Giuseppe Luigi Banna, Alessio Signori, et al. · European Journal of Cancer · 10
Supportive Care of Patients Undergoing Immunotherapy
2016 · Ronwyn van Eeden, Bernardo L Rapoport · European Oncology & Haematology · 5
Prognostic significance of neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small cell lung cancer
2019 · B.L. Rapoport, D.A. Vorobiof, et al. · Annals of Oncology · 3
Durable remissions associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center
2017 · T. Smit, B.L. Rapoport, et al. · Annals of Oncology · 3
PDF
Triple-Negative Breast Cancer – The Past, Present and Future: Recent and Emerging Trends in Immunotherapy
2016 · Ronwyn van Eeden, Bernardo L Rapoport · Breast Cancer Management · 3
PDF
Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
2017 · Bernardo Leon Rapoport, Teresa Smit, et al. · Journal of Clinical Oncology · 2
Immunotherapy for cancer
2021 · R Van Eeden · South African General Practitioner · 1
Abstract P1-10-14: Focus on tumor infiltrating lymphocytes (TIL’s): High levels of spatially positioned CD3 and CD8 cells and high immunoscores are significantly associated with pathological complete responses in triple-negative breast cancer patients
2020 · Bernardo Leon Rapoport, Simon Nayler, et al. · Cancer Research · 1
High incidence of nausea during initial and repeated courses if intravenous chemotherapy in patients receiving guideline consistent antiemetic prophylaxis: A prospective, observational, real-world study
2019 · T. Smit, R.I. Van Eeden, et al. · Annals of Oncology · 1
PDF
Experience of immune-related adverse events associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center
2017 · B.L. Rapoport, T. Smit, et al. · Annals of Oncology · 1
Immune related adverse events associated with ipilimumab and nivolumab
2017 · B. Rapoport, R.I. Van Eeden, et al. · Annals of Oncology · 1
Experience of immune-related adverse events associated with ipilimumab and nivolumab in a single center.
2017 · Bernardo Leon Rapoport, Teresa Smit, et al. · Journal of Clinical Oncology · 1
Abstract P2-16-20: Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67
2020 · Bernardo Leon Rapoport, Jacqui Barnard-Tidy, et al. · Cancer Research
02 - High Incidence of Nausea During Initial and Repeated Courses of Intravenous Chemotherapy in Patients Receiving Guideline Consistent Anti-emetic Prophylaxes– a Prospective, Observational, Real World Study
2019 · Teresa Smit, Prof Bernardo Leon Rapoport, et al.
01 - Immune-related Adverse Events Associated With Anti-ctla-4 and Anti-pd-1 Checkpoint Inhibitors. a Single Center Experience
2019 · Teresa Smit, Dr Ronwyn Van Eeden, et al.
P3.13-021 Can Lymph Nodes Visualized on PET/CT Predict the Outcome of Patients with Lung Cancer?
2017 · M. Vangu, R. Van Eeden, et al. · Journal of Thoracic Oncology
Management and Supportive Care of Patients Undergoing Immunotherapy
2017 · Bernardo L. Rapoport, Ronwyn van Eeden · InTech eBooks
PDF
Works count: 27
Citation count: 282
H-index: 9
I10-index: 9
Year
Topic
Type